{
  "url": "https://openlegislation.uk/national-health-service-general-medical-services-contracts-wales-regulations-2023/schedule-3/paragraph-128",
  "json_url": "https://openlegislation.uk/national-health-service-general-medical-services-contracts-wales-regulations-2023/schedule-3/paragraph-128.json",
  "legislation": "wsi/2023/953",
  "legislation_title": "The National Health Service (General Medical Services Contracts) (Wales) Regulations 2023",
  "legislation_url": "https://openlegislation.uk/national-health-service-general-medical-services-contracts-wales-regulations-2023",
  "path": "schedule/3/paragraph/128",
  "kind": "paragraph",
  "number": "128",
  "heading": "Clinical governance",
  "text": "(1) The contractor must have in place an effective system of clinical governance which includes appropriate standard operating procedures in relation to the management and use of controlled drugs.\n(2) The contractor must nominate a person who has responsibility for ensuring the effective operation of the system of clinical governance.\n(3) The contractor must engage in discussion and peer review of clinical incidents that have occurred within the practice and local services.\n(4) Components of the ‘system of clinical governance’ include, but are not limited to, the contractor—\n(a) undertaking annually by 31 March—\n(i) the Clinical Governance Practice Self-Assessment Tool, and\n(ii) the Information Governance Toolkit,\nand submitting evidence of completion to the Local Health Board on request, and\n(b) complying with the Assurance Framework and the Local Health Board’s use of that Assurance Framework in relation to the contractor.\n(5) The person nominated under sub-paragraph (2) must be a person who performs or manages performance of services under the contract.\n(6) In this paragraph—\n“system of clinical governance” (“system llywodraethu clinigol”) means a framework through which the contractor endeavours continuously to improve the quality of its services and safeguard high standards of care by creating an environment in which clinical excellence can flourish;\n“controlled drugs” (“cyffuriau a reolir”) has the meaning given in section 2 of the Misuse of Drugs Act 1971 (which relates to controlled drugs and their classification for the purposes of that Act).",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 3 para. 128 in force at 1.10.2023, see reg. 1(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/wsi/2023/953/schedule/3/paragraph/128",
    "retrieved_at": "2026-10-28T23:03:15.623214+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}